Vaccine vs RSV, common but deadly virus, approved
MANILA, Philippines—The US Food and Drug Administration (FDA) has approved the use of a vaccine against the respiratory syncytial virus (RSV)—a respiratory disease that sends over 177,000 elderly people in the US to hospitals each year, and is also common among Filipino children. Multinational pharmaceutical and biotechnology company GSK’s Arexvy vaccine on May 03 was […]
The post Vaccine vs RSV, common but deadly virus, approved appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.